Year: 2022

news_6

GC Biopharma Concludes Agreement With Acuitas Therapeutics for Lipid Nanoparticle Delivery System for Use in mRNA Vaccines and Therapeutics

YONGIN, South Korea & VANCOUVER, Canada--(BUSINESS WIRE)--GC Biopharma (006280.KS) and Acuitas Therapeutics, a company focused on developing lipid nanoparticle (LNP)...